We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Outlines Process for Using Advanced Therapies in Hospitals
MHRA Outlines Process for Using Advanced Therapies in Hospitals
August 17, 2009
Drugmakers seeking approval for advanced therapy medicinal products (ATMPs) to be used in UK hospitals do not need direct approval from the European Medicines Agency (EMEA) but still must get approval from the Medicines and Healthcare products Regulatory Agency (MHRA). Includes the full text of MHRA Draft Guidance on the Use of Advanced Therapies in Hospitals.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor